Relationship Between Vitamin D Deficiency and Markers of Metabolic Syndrome Among Overweight and Obese Adults
Abstract
In recent years, metabolic syndrome, obesity, diabetes and cardiovascular disease has had a tremendous elevation growth. Many studies have demonstrated negative correlation between vitamin D deficiency and indexes of metabolic syndrome in obese patients. This study was designed to find the relation between vitamin D deficiency and markers of metabolic syndrome among overweight and obese adults referred to obesity center of Shahid Sadoughi hospital in 2014. Eighty-nine overweight and obese adults (79 women and 10 men), who 13 subjects were overweight and 76 subjects were obese were recruited in this cross-sectional study. Total cholesterol, high-density lipoprotein cholesterol, triglyceride, plasma glucose and vitamin D were measured. IDF criteria were used for identifying subjects with metabolic syndrome. Demographic questionnaire was completed. Statistical analysis was performed using SPSS version 16.0. Fisher exact test, logistic regression, and Spearman correlation coefficient were used. The frequency of vitamin D deficiency was 93.2%. According to IDF criteria, the frequency of metabolic syndrome was 36%. There was no significant relationship between vitamin D deficiency and metabolic syndrome. Among metabolic syndrome indicators, there was a significant direct relationship between vitamin D level with FBS (P=0.013) and SBP (P=0.023). There was no significant relationship between vitamin D deficiency and metabolic syndrome. Due to the lack of relationship between vitamin D deficiency and metabolic syndrome, small number of participants in this study and very low case of normal vitamin D level, further studies are needed.
Moradzadeh K, Larijani B, kestkar A, Hosseinnejad A,rajabian R, Nabipour I, et al. Normal vitamin D levels andthe prevalence of vitamin D deficiency in Iran. JKordestan Univ Med Univ 2006;10:33-43.
Paknahad Z, Ahmadivasmehjani A, Maracy MR.Association of Serum 25-hydroxyvitamin D concentrationand Markers of Metabolic Syndrome in adult women. JRes Health Sys 2015;11:641-50.
Gannagé-Yared M-H, Chedid R, Khalife S, Azzi E,Zoghbi F, Halaby G. Vitamin D in relation to metabolicrisk factors, insulin sensitivity and adiponectin in a youngMiddle-Eastern population. Eur J Endocrinol2009;160:965-71.
Mackawy AM, Badawi ME. Association of vitamin Dand vitamin D receptor gene polymorphisms with chronicinflammation, insulin resistance and metabolic syndromecomponents in type 2 diabetic Egyptian patients. MetaGene 2014;2:540-56.
Hjelmesæth J, Hofsø D, Aasheim ET, Jenssen T, Moan J,Hager H, et al. Parathyroid hormone, but not vitamin D, isassociated with the metabolic syndrome in morbidlyobese women and men: a cross-sectional study. J DiabetesMetab Disord 2009;8:7.
Alberti K, Eckel RH, Grundy SM, Zimmet PZ, CleemanJI, Donato KA, et al. Harmonizing the metabolicsyndrome a joint interim statement of the internationaldiabetes federation task force on epidemiology andprevention; national heart, lung, and blood institute;American heart association; world heart federation;international atherosclerosis society; and internationalassociation for the study of obesity. Circulation2009;120:1640-5.
McNeill AM, Rosamond WD, Girman CJ, Golden SH,Schmidt MI, East HE, et al. The metabolic syndrome and11-year risk of incident cardiovascular disease in theatherosclerosis risk in communities study. Diabet Care2005;28:385-90.
Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al.Plasma 25-hydroxyvitamin D concentration andmetabolic syndrome among middle-aged and elderlyChinese individuals. Diabet Care 2009;32:1278-83.
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome- anew world-wide definition.A Consensus Statement fromthe International Diabetes Federation. Diabet Med.00-664:22;6002
Botella-Carretero JI1, Alvarez-Blasco F, Villafruela JJ,Balsa JA, Vázquez C, Escobar -Morreale HF.Vitamin Ddeficiency is associated with the metabolic syndrome inmorbid obesity. Clin Nutr 2007;26:573-80.
Bonakdaran S, Varasteh A, Khaajeh-Dalouie M. Serum 25 hydroxy vitamin D3 and laboratory risk markers ofcardiovascular diseases in type 2 diabetic patients. JDiabetes Metab Disord 2010;11:504-9.
Ford ES, Ajani UA, McGuire LC, Liu S. Concentrationsof serum vitamin D and the metabolic syndrome amongUS adults. Diabetes Care 2005;28:1228-30.
Reis JP, von Mühlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels withmetabolic syndrome among US adults. Eur J Endocrinol2008;159:41-8.
Brock KE, Ke L, Koo F, Jang H, Clemson L, Mpofu E, etal. Vitamin D and metabolic syndrome in immigrant EastAsian women living in Sydney, Australia: a pilot. J Metab
Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: ameta-analysis. J Hypertens 2011;29:636-45.
Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator ofthe renin-angiotensin system. J Clin Invest-5504662;6006.60
Park HY, Lim YH, Kim JH, Bae S, Oh SY, Hong YC.Association of serum 25 -hydroxyvitamin D levels withmarkers for metabolic syndrome in the elderly: a repeatedmeasure analysis. J Korean Med Sci 2012;27:653-60.
| Files | ||
| Issue | Vol 55, No 6 (2017) | |
| Section | Original Article(s) | |
| Keywords | ||
| Metabolic syndrome Obesity Vitamin D Type 2 diabetes mellitus | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
